Variant report
Variant | esv2761177 |
---|---|
Chromosome Location | chr8:5069057-5076672 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12549617 | chr8:5069057-5069058 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs574577233 | chr8:5069074-5069075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs4392923 | chr8:5069082-5069083 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs552846965 | chr8:5069114-5069115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143178980 | chr8:5069137-5069138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572404715 | chr8:5069173-5069174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs546096155 | chr8:5069207-5069208 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571701483 | chr8:5069226-5069227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564199524 | chr8:5069246-5069247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541993770 | chr8:5069273-5069274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs138685087 | chr8:5069277-5069278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188009657 | chr8:5069298-5069299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192638649 | chr8:5069306-5069307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141124053 | chr8:5069321-5069322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11986432 | chr8:5069324-5069325 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs574659006 | chr8:5069379-5069380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527651311 | chr8:5069384-5069385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184943569 | chr8:5069398-5069399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs35090293 | chr8:5069452-5069453 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs188214084 | chr8:5069453-5069454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563536291 | chr8:5069512-5069513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146959253 | chr8:5069526-5069527 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114036225 | chr8:5069529-5069530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs137961835 | chr8:5069534-5069535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs568190408 | chr8:5069542-5069543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535530651 | chr8:5069554-5069555 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192161712 | chr8:5069563-5069564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532346402 | chr8:5069571-5069572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73188893 | chr8:5069592-5069593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs11997861 | chr8:5069604-5069605 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs576246382 | chr8:5069630-5069631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543646673 | chr8:5069643-5069644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374583733 | chr8:5069644-5069645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150446127 | chr8:5069649-5069650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs530167181 | chr8:5069656-5069657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10096941 | chr8:5069682-5069683 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs11777286 | chr8:5069685-5069686 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs9314560 | chr8:5069719-5069720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184710758 | chr8:5069733-5069734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572744681 | chr8:5069751-5069752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189421203 | chr8:5069819-5069820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs571171109 | chr8:5069832-5069833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs182024445 | chr8:5069841-5069842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538673956 | chr8:5069851-5069852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568689236 | chr8:5069855-5069856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536031535 | chr8:5069861-5069862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553909769 | chr8:5069890-5069891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565599384 | chr8:5069923-5069924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs118033336 | chr8:5069928-5069929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557462350 | chr8:5069951-5069952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:5065000-5070000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr8:5066200-5070000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr8:5069200-5069600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr8:5069600-5070000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr8:5070000-5070200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr8:5070000-5070600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr8:5070000-5070600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr8:5070000-5071200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr8:5070200-5071000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr8:5070200-5071000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr8:5071000-5071800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr8:5073400-5073800 | Active TSS | Spleen | Spleen |